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Abstract
Introduction: It is difficult to treat patients who, in addition to having severe anorexia nervosa,
also have severe symptoms of major depressive disorder and a tendency for impulsive acting out
behaviour. Our case report considers the feasibility of maintenance electroconvulsive therapy in
such complicated cases.
Case presentation: This is a case report of a woman with anorexia nervosa and co-morbid
severe major depressive disorder who was treated with electroconvulsive therapy as a
maintenance treatment.
The maintenance electroconvulsive therapy was conducted without immediate complications. It
had a positive effect on the patient's depressive symptoms and lability and her general wellbeing,
although some cognitive deficits were observed.
Conclusion: The maintenance electroconvulsive therapy seemed to support recovery in a case of
refractory anorexia nervosa and a tendency for labile mood. The symptoms of co-occurring major
depressive disorder were partly relieved and maintenance electroconvulsive therapy had some
positive effect on weight gain.
Introduction
Psychiatric co-morbidity in eating disorders is high. Affec-
tive disorders co-exist most frequently with eating disor-
ders [1,2]. There is no consensus on treatment guidelines
in eating disorders [3], and the role of antidepressants
(AD) is not clear [4], although in case of co-existing major
depressive disorder (MDD) using AD is obvious. Electro-
convulsive therapy (ECT) has been among the treatment
choices for eating disorders but studies on its effectiveness
are only case reports [5-7]. Maintenance ECT (mECT) has
a role in the treatment of refractory MDD, although some
memory deficits have been reported [8]. The association
between cognitive decline and mECT seems to be non-sig-
nificant [9].
We have a patient with severe anorexia nervosa whose
concurrent MDD was successfully treated with mECT.
Case presentation
The long-term treatment period of a Finnish, ethnically
Caucasian, 21-year-old high school graduate and shop
assistant, started when she was admitted to the acute ward
of the local psychiatric hospital in August 2007 with a
diagnosis of anorexia nervosa according to the criteria of
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she was 13 and began to exercise and avoid fattening
food. Her weight dropped from 78 kg to 49 kg (her height
is 178 cm) in a few months. At that time her parents were
having severe marital problems. However, the parents did
not separate or divorce. At the same time Ms. P.M. had
started high school in a boarding school about 50 km
away from her home, which was an exceptional choice as
boarding schools are a rarity in Finland.
During the first months of her eating disorder she had
psychiatric outpatient treatment, but in summer 2002 her
condition deteriorated as she started bulimic behaviour
and vomiting, and also had symptoms of depression
(depressive mood, loss of pleasure, low energy, insom-
nia). In September 2003 she was admitted to the Depart-
ment of Adolescence Psychiatry, Tampere University
Hospital and hospitalized for two months. During her
hospital treatment she had no psychotropic medication.
Her relationship to her parents was found to be exception-
ally close and she had only one friend of her own age.
There were many unsolved family problems but abuse
was not among them. However, the eating disorder had
brought the parents closer to each other, which pleased
the patient.
The patient subsequently resumed psychiatric outpatient
treatment until spring 2005. The outpatient treatment
consisted of visits to a psychologist with CBT training
once a week, psychotropic medication (fluoxetine 40-60
mg/day), and nutritional advising. She was able to com-
plete her high school studies with good grades in May
2005. She then got a job as a shop assistant. She moved
away from her parents' home with her only (female)
friend as a room-mate. She also began occasionally dating
a boyfriend of her own age and the relationship was a
good one. In summer 2007 her room-mate moved to
another town to work. Soon after that the patient's eating
disorder became more severe and she had amenorrhoea.
She also began to mutilate herself with a knife and to
drink quite a lot of alcohol (cider). She was admitted to
the acute ward of the local psychiatric hospital in August
2007. At that time her weight was 56.2 kg and Body Mass
Index (BMI) 17.7. The patient's hospital treatment was
then two months. After that there was an outpatient
period of seven weeks, a new hospital treatment of one
month, and again an outpatient treatment of six weeks.
Poor compliance was the biggest problem in this outpa-
tient treatment.
Since the beginning of April 2008 she has been almost
continuously hospitalised for more than a year (there was
a short period of outpatient treatment in August 2008).
She began her psychiatric inpatient treatment again in the
local hospital. At the beginning of summer 2008 her
weight was 40.0 kg and BMI 12.6. At that time she was
admitted for two weeks for rapid nasogastric refeeding on
the medical ward of the local hospital. Her weight rose to
49.6 kg in only two weeks, making her mood more and
more anxious. Thereafter she was admitted to the psychi-
atric ward of the University Hospital, again for four days
on the medical ward of the University Hospital, and then
back to the psychiatric ward. Besides anorexia nervosa
(F50.0), major depressive disorder (MDD; F32.2) was also
diagnosed according to the criteria of the ICD-10. Her
symptoms of depression were: lowering of mood, reduc-
tion of energy, decrease in activity, reduced capacity for
enjoyment and interest, hopelessness, appetite dimin-
ished, feelings of worthlessness, agitation and suicidal
acts. She had delusional thoughts about her body shape
and weight. She totally refused to eat and regarded even
water as a fattening foodstuff. She tried to vomit aggres-
sively and exercise physically all the time. Mechanical
restraints, nasogastric refeeding, and constant observation
24 hours a day were provided. She nevertheless managed
to abuse herself by hysterical cutting and vomiting. At that
time her medication included fluoxetine (60 mg/day) and
olanzapine (30 mg/day) and also lorazepam (2 mg/day)
before main meals. Later on fluoxetine was supplied in a
combination of venlafaxine (150 mg/day) and mirtazap-
ine (60 mg/day). Because the symptoms of MDD were not
relieved with AD treatment, ECT was used. ECT was
administered three times a week. Anaesthesia was induced
with methohexital and muscle relaxation with succinyl-
choline. Physiological monitoring included pulse oxime-
try, blood pressure, ECG, four channel EEG and EMG. She
had ten bifrontotemporal ECT sessions in July 2008. The
psychotropic medication was continued during the ECT
treatment. There were no anaesthetic complications. The
respective Beck Depression Inventory (BDI) [10] scores
were 52 and 35 before and after the ECT treatment, mean-
ing that her depression was not totally relieved. Clinically,
the patient was satisfied with the outcome of the ECT, her
behaviour continued to be self-destructive but her mood
was better, she was more active, no longer hopeless, no
longer delusional, and her appetite was no longer
impaired. BMI had risen only slightly from 15.0 to 15.3.
She continued exercising but the vomiting had dimin-
ished.
In August 2008 she first spent three weeks on the psychi-
atric ward of the local hospital and then returned to the
psychiatric ward of the University Hospital with BMI only
13.8. She had started to exercise aggressively again. At the
beginning of September 2008 her BMI was only 12.2. Two
short treatment periods of nasogastric refeeding on the
medical ward were initiated. She then requested a new
series of ECT. Before the ECT her BDI was 35, her Mont-
gomery-Åsberg Depression Rating Scale (MADRS) [11],
score 28 and BMI 14.2. After 12 bifrontotemporal ECTPage 2 of 4
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slightly better according to MADRS (scoring 24) and she
began to smile, but she was acting out (lying and stealing)
and the self-rated BDI was higher than it was before the
ECT: 43. Vomiting and exercising had diminished quite a
lot. In October 2008 she was transferred to a psychiatric
ward specialized in treating refractory patients. At that
time a decision was taken on mECT: bifrontotemporal
ECT once a week or once in two weeks. The medication
was again supplied: quetiapine (600-800 mg/day) was
used instead of olanzapine and fluoxetine (60-70 mg/
day) instead of other ADs. She had creative art therapy
and physiotherapy in order to improve her body image of
which physiotherapy was of some help by teaching the
patient to relax. In December 2008 she was allowed to
spend some days at (her parents') home. By the end of
2008 BMI was16.4 and she had no symptoms of depres-
sion. During the first weeks of 2009 mECT was only given
once in 4 weeks. Very soon she became anxious again and
started exercising, stealing sweets, binge eating, vomiting
with the help of various hoses, and evacuating her rectum.
Her mood became low and she was tired and hopeless. In
the middle of February 2009 the frequency of mECT was
then temporarily increased to twice a week for two
months. Her mood improved and she was active and opti-
mistic. Her weight remained at 50-51 kg (BMI about 16)
until the beginning of April. The most aggressive exercis-
ing and vomiting faded away. Then quetiapine was
changed to aripiprazole (20-30 mg/day), and at the same
time the frequency of mECT was changed to once in 2
weeks. A new type of therapy was also initiated: the
patient was given more responsibility for her own behav-
iour and the use of strict weight limits in order to obtain
new benefits was abandoned. Her mood remained in bal-
ance and the acting out behaviour (stealing, lying, hyster-
ical cutting) declined, but her weight dropped rapidly
from 51 kg to 46 kg (BMI 14.5) in only eight weeks.
Ms. P.M. underwent a series of 10 ECT in the summer, a
series of 12 ECT in the autumn, and a total of 23 mECTs
during the winter and spring 2008-9. In order to control
for possible side-effects of the mECT, a magnetic reso-
nance image (MRI) of her head was taken and a psychol-
ogist's assessment was conducted in May 2009. The MRI
was normal. Maintenance ECT was discontinued in order
to get a psychologist's assessment of memory functions
during a four-week time free of ECT. Soon depressive
symptoms again became prominent: low mood, reduc-
tion in energy, difficulties in concentrating, but no hope-
lessness or suicidality. BMI remained low at 14.5.
However, according to the psychologist's assessment in
May 2009, the patient's cognitive capacity had been
impaired during the last 21 months. A shorter psycholog-
ical assessment had been conducted in August 2007 and
at that time the patient's cognitive skills were clearly better
(IQ was 116 in August 2007 and 102 in May 2009). More-
over, her memory functions three weeks after the latest
ECT yielded a very uneven memory profile, indicating dif-
ficulties in verbal memory (word lists) possibly due to
fluctuating attention. The psychologist's assessment even
suggested that the patient's semantic memory might have
deteriorated. As we did not want to expose her to possible
difficulties with memory the idea of more mECT was
abandoned.
She has now been 10 weeks without mECT. Her regular
medication has been aripiprazole 30 mg/day, fluoxetine
60 mg/day and lorazepam 1 mg twice a day before main
meals. At first her mood became depressive, but after 5-6
weeks she was no longer depressive but only feeling down
once in a while. Her BMI has slightly risen from 14.8 to
15.3.
Discussion
Contraindications for ECT in general and in eating disor-
ders are few: Disturbances in electrolytes may elevate the
risk of anaesthesiologic complications. Low body weight
is not as such a contraindication for ECT [12]. The role of
mECT in the treatment of recurrent depression is not con-
sistent [8] and there are no studies about its effectiveness
in eating disorders. In our case, mECT seemed to have a
stabilizing effect on the patient's mood in a situation
including not only anorectic and bulimic behaviour but
also MDD and multiple acting out. A great benefit of the
ECT procedure was that the patient herself and her family
were strongly in favour of ECT and also of mECT.
The most common adverse effects of ECT are memory dis-
turbances consisting of both anterograde and retrograde
amnesia [13]. Anterograde memory defect usually disap-
pears in a few days or weeks after completion of the ECT
course [12]. In objective measures retrograde memory loss
has been found to disappear 6 months post treatment
[14]. Difficulties with verbal and semantic memory are
not the most typical consequences of ECT but some evi-
dence of deteriorating verbal memory following ECT has
been reported [15]. It is possible that in this case impaired
cognitive capacity and difficulties with verbal memory
were not consequences of mECT but a result of a long-
term treatment period on a ward for seriously mentally ill
patients (consequences of institutionalization), or they
were consequences of MDD, or consequences of malnu-
trition. It is also possible that the patient had early co-
morbid symptoms of some other psychiatric disorder e.g.
a functional psychosis.
Our patient had many kinds of treatments. The role of
psychotropic medication, creative art therapy, physiother-
apy or clinical therapeutic principles was not under obser-
vation here. But for instance when the patient was givenPage 3 of 4
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more responsibility for her own behaviour in April, it was
clearly too much for her. In spite of her mood being in
better balance her weight dropped rapidly.
Conclusion
ECT seemed to have a stabilizing effect on the mood and
some positive effect on weight gain. The changes in symp-
toms were transient with ECT but slightly more stable
with mECT with a frequency of at least once in two weeks.
Altogether we suggest that ECT is a treatment option when
a patient has an eating disorder and co-morbid severe
MDD. As maintenance treatment mECT seemed to sup-
port recovery in a case of refractory anorexia nervosa and
a tendency for labile mood. The risk of memory dysfunc-
tions after mECT, however, requires further research.
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